Last reviewed · How we verify
NCT03207841
Low Carbohydrate/High Protein Diet to Improve Metabolic Health
NA trial testing LC/HP in Spinal Cord in 60 participants. Completed in 29 August 2022.
1 August 2022
Quick facts
| Lead sponsor | Ohio State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 1 November 2017 |
| Primary completion | 1 August 2022 |
| Estimated completion | 29 August 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- LC/HP
Conditions studied
- Spinal Cord — all drugs for Spinal Cord →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Diabetes — all drugs for Diabetes →
Sponsor
Ohio State University
Who can join
Adults 18 to 60, any sex, with Spinal Cord or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Individuals with spinal cord injury (SCI) are living to ages when metabolic disorders are highly prevalent. The combination of impaired glucose tolerance and insulin resistance can disrupt lipid metabolism and increase the risk of cardiovascular disease and diabetes, and contribute to an accelerated aging process in the SCI population. Feasible interventions to improve metabolic function in the chronic SCI are in great demand. Compared to pharmacologic therapies, dietary modification is a more cost-effective treatment option for reducing the risk of metabolic dysfunction that, surprisingly, has not been rigorously investigated in people with SCI. Therefore, in the present study the investigators will investigate the efficacy of an 8-week, eucaloric (a meal plan designed specifically to provide the exact amount of calories needed to maintain a given body weight) LC-HP dietary intervention for improving metabolic function, body composition, gut bacteria composition and quality of life in individuals with SCI and impaired glucose tolerance or type 2 diabetes. The investigators also aim to determine the association between changes in the composition of gut bacteria and improvements in metabolic function and the association between improvements in metabolic function and improvements in quality of life.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of a low-carbohydrate/high-protein diet on metabolic health in individuals with chronic spinal cord injury: An exploratory analysis of results from a randomized controlled trial.
Li J, Gower B, McLain A, Yarar-Fisher C. · · 2022 · cited 11× · PMID 36411989 · DOI 10.14814/phy2.15501 -
Utilizing a low-carbohydrate/high-protein diet to improve metabolic health in individuals with spinal cord injury (DISH): study protocol for a randomized controlled trial.
Yarar-Fisher C, Li J, McLain A, Gower B, et al · · 2019 · cited 11× · PMID 31362773 · DOI 10.1186/s13063-019-3520-3
Verify or expand the search:
- PubMed search for NCT03207841
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spinal Cord
Currently open trials in the same condition.
- NCT06204315 — Risk Adapted Spinal Cord/Cauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compres · Phase 2 · recruiting
- NCT06548776 — Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord · NA · recruiting
Other Ohio State University trials
Trials by the same sponsor.
- NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
- NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
- NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
- NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
- NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03207841 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University
- Last refreshed: 27 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03207841.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing